HOME / Featured News / WORLD NEWS
Whistleblowers Sue FDA, Claim Emails Monitored
Rate This Article:
0
MedpageToday.com REPORTS HERE that "six former FDA scientists are suing the agency, saying it unlawfully monitored personal email accounts from their work computers after the scientists complained to Congress about allegedly unsafe medical devices gaining approval."

"According to the Washington Post, scientists and doctors within the Center for Devices and Radiological Health (CDRH) first made internal complaints starting in 2007 that the agency had approved or was close to approving at least a dozen radiological devices that had not been shown to work and may have posed risks to patients."

"The lawsuit, which was filed in the U.S. District Court for the District of Columbia last week, notes that in 2008 an FDA scientist wrote a letter to Congress with allegations that senior managers at the FDA's CDRH 'ordered, intimidated, and coerced FDA experts to modify their scientific reviews, conclusions, and recommendations in violation of the law.'"

"FDA officials became aware of that letter when a high-ranking member of Congress sent a letter to FDA officials outlining the allegations. In early 2009, nine FDA scientists sent another letter, this one to President Obama's transition team, alleging 'corruption within the FDA device review process, managerial misconduct, dangers to public health, welfare and safety, and retaliation against whistle-blowers.'"

"FDA higher-ups also learned of that letter, began to refer to the scientists as the 'FDA Nine,' and started to secretly monitor their work computers via spyware software for emails and other communications relating to their whistle-blowing activities, according to the lawsuit."

"Around that time, Sen. Charles Grassley (R-Iowa) told FDA Commissioner Andrew Von Eschenbach, MD, that 'FDA employees have a right to talk to Congress without interference and/or threats from the Agency ... [and] they have a right to talk to Congress confidentially,' according to the lawsuit." In a recent statement, Grassley said, 'It's hard to see how managers apparently thought it was a good use of time to shadow agency scientists and monitor their email accounts for legally protected communications with Congress.' He added that the FDA "appears to have persisted in a long campaign to punish a group of employees for talking to Congress ... I've seen this kind of behavior from the FDA before, and it's troubling to think there might be a pattern.'"

"The staffers were all eventually fired from their positions in the CDRH, according to the lawsuit, mostly by not having their contracts renewed when they expired. FDA computers post a warning when users log on alerting them that they should have "no reasonable expectation of privacy regarding any communication or data passing through or stored on the system" and that the government may intercept any of the data at any time."

"Lawyers for the FDA scientists, however, argue that the scientists were told by the FDA that they could use their computers for personal purposes, and thus they had a "reasonable expectation of privacy." (The email communications about whistle-blowing activities were via the scientists' private Gmail or Yahoo accounts.) The FDA staffers are accusing the FDA of violating their Fourth Amendment rights, which protect against illegal searches and seizures, and their Fifth Amendment rights, which protect against abuse of government authority. Collecting emails to use against the scientists created a "chilling effect" on free speech, so the FDA also is guilty of violating their First Amendment rights, lawyers for the plaintiffs argued."

"According to the lawsuit, the FDA twice attempted to have the employees criminally investigated by HHS' investigatory arm -- the Office of the Inspector General (OIG). OIG responded that 'the referral lacks any evidence of criminal conduct on the part of any HHS employee,' adding that a federal whistle-blower law protects the types of disclosures they made. The Department of Justice also allegedly turned down a request to investigate the scientists for wrongdoing."

"The lawsuit doesn't detail all of the devices that were of concern to the scientists, but the Washington Post reported that three of the devices were for detecting signs of breast cancer; several were were screening for colon cancer; one was meant to detect osteoporosis; and another was for monitoring pregnant women in labor. One of the FDA scientists reviewed a CT colonography device and concluded the device wasn't effective or safe and emitted so much radiation that a single exam with the device would be equal to receiving 800 chest x-rays."

"The plaintiffs are seeking a judgment that the U.S. government cannot search employees' private email without "due process" and cannot target whistle-blowers without search warrants."

 
Post A Comment
* Indicates Required Field
Comment Title:
* Comments:
Nickname:
* Validation:
Most Recent Comments
 
 
FeaturedNews
Clinical Trial Data Should Be Open for Review
Published 04/30/2012 - 3:14 p.m.  CDT

Original clinical study reports, which contain far more detail than published randomized trials, should be made available to independent researchers seeking to verify efficacy and safety claims.

In support of this argument, the history of the influenza antiviral oseltamivir (Tamiflu), which was approved by the FDA in 1999, was cited. The widespread belief in oseltamivir's efficacy, was based on a meta-analysis of 10 trials conducted by the manufacturer prior to licensure.  But the authors pointed out that the FDA, which was aware of these clinical trials, concluded that oseltamivir had not been shown to reduce complications and required a statement on the drug's label to that effect.  Moreover, oseltamivir was not given an FDA indication for prevention of spread of influenza.

To this, [authors] commented, "If FDA is right, the drug's effectiveness may be no better than aspirin or acetaminophen.'"
...Read More
HR 329 in need of Co Sponsors
Published 04/30/2012 - 11:11 a.m.  CDT

Representative Bob Filner recently introduced the Chiropractic Care to All Veterans Act (H.R. 329). The bill would require the Veterans Administration (VA) to have a chiropractic physician on staff at all major VA medical facilities by 2014. You too can help ensure chiropractic care is available to those who have placed their lives in service to our country. H.R. 329 is in need of cosponsors to assist its likelihood of passage.

CLICK HERE to urge your legislators to cosponsor the bill.
...Read More
Court Sides with Generic-Drug Makers
Published 04/25/2012 - 6:33 a.m.  CDT

In a unanimous decision, the Supreme Court ruled that generic drugmaker Caraco Pharmaceutical Laboratories can sue Novo Nordisk for what Caraco says are exaggerated descriptions of the scope of patents Novo Nordisk holds on a diabetes drug.

A group of Democratic senators has introduced a bill that would allow people to sue generic drugmakers over failing to update their drug labels to include all known risks. The bill is meant to counter last year's Supreme Court decision in a generic drug dispute.
...Read More
Reader Login
Username:
Password:
 Save Login?
Free Sign-up
Forgot Password?
Reader Control Panel

The TCA Web sites will be under going change in the next few weeks.  Please bear with us while we complete some improvements.

Original clinical study reports, which contain far more detail than published randomized trials, should be made available to independent researchers seeking to verify efficacy and safety claims.

In support of this argument, the history of the influenza antiviral oseltamivir (Tamiflu), which was approved by the FDA in 1999, was cited. The widespread belief in oseltamivir's efficacy, was based on a meta-analysis of 10 trials conducted by the manufacturer prior to licensure.  But the authors pointed out that the FDA, which was aware of these clinical trials, concluded that oseltamivir had not been shown to reduce complications and required a statement on the drug's label to that effect.  Moreover, oseltamivir was not given an FDA indication for prevention of spread of influenza.

To this, [authors] commented, "If FDA is right, the drug's effectiveness may be no better than aspirin or acetaminophen.'"

The Kilgore College Small Business Development Center (SBDC) will sponsor an educational seminar for medical office staff, including office managers and billing staff, entitled Basic Workers’ Compensation for Medical Office Staff on Wednesday, May 2, 2012.

Representative Bob Filner recently introduced the Chiropractic Care to All Veterans Act (H.R. 329). The bill would require the Veterans Administration (VA) to have a chiropractic physician on staff at all major VA medical facilities by 2014. You too can help ensure chiropractic care is available to those who have placed their lives in service to our country. H.R. 329 is in need of cosponsors to assist its likelihood of passage.

CLICK HERE to urge your legislators to cosponsor the bill.

An $8 billion Medicare demonstration program is poorly designed and should be cancelled, the nonpartisan Government Accountability Office (GAO) said. The program is designed to reward the highest-quality Medicare Advantage plans, but instead pays out most of its award money to mediocre plans, according to a report.


Ethiopia and Kenya Trips.  Have you ever wanted to provide chiropractic care in another country and give back to those in need?

Dr. Teresa Jones has been volunteering on mission trips to Africa for 4 years and is reaching out to the District 5 for help this year. There are two chances to participate, both in July 2012 and if you are interested please RSVP to frontdesk@wholehealth-care.com to let her know you area interested!


The Patient-Centered Outcomes Research Initiative (PCORI), established by the 2010 Patient Protection and Affordable Care Act, has set five priorities as the group's research agenda for the coming years, with the overall goal of advancing clinical effectiveness research. …. the priorities [are] as follows...

Girls who face multiple social stressors at home as toddlers are more likely to be obese by age 5, researchers found.

Nonpharmacologic pain management appears to be safe for mother and baby, although there is limited published evidence to explain its efficacy, according to a Cochrane Review.

There is more data to support the ef?cacy of pharmacologic pain management, such as epidurals and opioids, but these methods lead to more adverse effects.  This reports reports upon some of these
Regulators on both sides of the Atlantic were slow to inform patients and their doctors about problems with metal-on-metal hip implants and relied on industry officials and consultants in crafting their responses.

Complications included high failure rates and possible systemic effects from elevated metal ion levels in the blood.  An advisory has been issued to surgeons, telling them that patients who have received metal-on-metal implants should have annual checkups for life. The evaluations should include testing for metal ions in the blood as well as for clinical symptoms of device failure.